For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today ...

TIESA will use Open-LIFU in AI-guided, noninvasive research on neuromodulation for mental health conditions. SAN ...

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...

Please provide your email address to receive an email when new articles are posted on . Researchers examined the effects of a remote neuromodulation device in patients with migraine. At 2 hours, pain ...

Even with the promise of multiple vaccines and eventual reopenings, the COVID-19 pandemic has made the value of telehealth clear, and it’s here to stay. Now, Abbott is launching a virtual clinic that ...

Pulsetto Bilateral Cervical Neuromodulation Device Evaluation: Session Duration, General Wellness Positioning, User-Reported ...

The global neuromodulation devices market is poised to witness substantial growth, projected to expand at a CAGR of 9–11% over the next five years. This growth is primarily driven by the increasing ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

A portable neuromodulation device can put the user in a meditative state with the potential to ease chronic pain, according to its teenage inventors. The Fluxwear Shift pulses electromagnetic energy ...